NL8600976A - (-)-1 beta-ethyl-1 alfa-hydroxymethyl-1,2,3,4,6,7,12,12 b alfa-octahydroindool2,3-achinolizine, werkwijze voor de bereiding ervan en farmaceutische preparaten met een dergelijke verbinding erin. - Google Patents

(-)-1 beta-ethyl-1 alfa-hydroxymethyl-1,2,3,4,6,7,12,12 b alfa-octahydroindool2,3-achinolizine, werkwijze voor de bereiding ervan en farmaceutische preparaten met een dergelijke verbinding erin. Download PDF

Info

Publication number
NL8600976A
NL8600976A NL8600976A NL8600976A NL8600976A NL 8600976 A NL8600976 A NL 8600976A NL 8600976 A NL8600976 A NL 8600976A NL 8600976 A NL8600976 A NL 8600976A NL 8600976 A NL8600976 A NL 8600976A
Authority
NL
Netherlands
Prior art keywords
formula
ethyl
compound
unit dose
quinolizine
Prior art date
Application number
NL8600976A
Other languages
English (en)
Dutch (nl)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NL8600976A publication Critical patent/NL8600976A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
NL8600976A 1985-04-19 1986-04-17 (-)-1 beta-ethyl-1 alfa-hydroxymethyl-1,2,3,4,6,7,12,12 b alfa-octahydroindool2,3-achinolizine, werkwijze voor de bereiding ervan en farmaceutische preparaten met een dergelijke verbinding erin. NL8600976A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU151985 1985-04-19
HU851519A HU194221B (en) 1985-04-19 1985-04-19 Process for preparing novel octahydro-indolo/2,3-a/quinoline derivative and pharmaceutical comprising this compound

Publications (1)

Publication Number Publication Date
NL8600976A true NL8600976A (nl) 1986-11-17

Family

ID=10954847

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8600976A NL8600976A (nl) 1985-04-19 1986-04-17 (-)-1 beta-ethyl-1 alfa-hydroxymethyl-1,2,3,4,6,7,12,12 b alfa-octahydroindool2,3-achinolizine, werkwijze voor de bereiding ervan en farmaceutische preparaten met een dergelijke verbinding erin.

Country Status (35)

Country Link
US (1) US4806545A (zh)
JP (1) JPH072637B2 (zh)
CN (1) CN1023560C (zh)
AR (1) AR240699A1 (zh)
AT (1) AT390954B (zh)
AU (1) AU591896B2 (zh)
BE (1) BE904588A (zh)
BG (1) BG60433B2 (zh)
CA (1) CA1299574C (zh)
CH (1) CH668262A5 (zh)
CS (1) CS274276B2 (zh)
DD (1) DD244556A5 (zh)
DE (1) DE3613180C2 (zh)
DK (1) DK159780C (zh)
EG (1) EG18059A (zh)
ES (1) ES8706152A1 (zh)
FI (1) FI83870C (zh)
FR (1) FR2580649B1 (zh)
GB (1) GB2174701B (zh)
GR (1) GR861027B (zh)
HU (1) HU194221B (zh)
IE (1) IE59199B1 (zh)
IL (1) IL78538A (zh)
IN (1) IN162810B (zh)
IT (1) IT1204306B (zh)
LU (1) LU86397A1 (zh)
NL (1) NL8600976A (zh)
NO (1) NO167143C (zh)
NZ (1) NZ215879A (zh)
PH (1) PH25316A (zh)
PT (1) PT82424B (zh)
SE (1) SE460196B (zh)
SU (1) SU1438612A3 (zh)
YU (1) YU44286B (zh)
ZA (1) ZA862941B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191454B (en) * 1984-10-05 1987-02-27 Richter Gedeon Vegyeszeti Gyar Rt.,Hu Process for producing amides of oktahydro-indolo/2,3-a/quinolyzin-1-yl-alkanecarboxylic acids and pharmaceutically acceptable acid additional salts thereof
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
HU194220B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof
HU207070B (en) * 1990-10-31 1993-03-01 Richter Gedeon Vegyeszet Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
IL164203A0 (en) * 2002-04-03 2005-12-18 Orion Corp Polycyclic compounds as potent alpah2-adrenoceptorantagonists
WO2003094917A1 (fr) * 2002-05-13 2003-11-20 Takata Seiyaku Co., Ltd. Composition medicinale contenant du vintoperol destinee a une administration transdermique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1499546A (en) * 1974-05-07 1978-02-01 Richter Gedeon Vegyeszet Indolo-quinolizidine derivatives and a process for the preparation thereof
HU170495B (zh) * 1974-05-07 1977-06-28
HU195214B (en) * 1985-04-19 1988-04-28 Richter Gedeon Vegyeszet Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
HU194220B (en) * 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof

Also Published As

Publication number Publication date
NO167143C (no) 1991-10-09
FI83870B (fi) 1991-05-31
AU591896B2 (en) 1989-12-21
DD244556A5 (de) 1987-04-08
ZA862941B (en) 1986-12-30
PH25316A (en) 1991-04-30
NO167143B (no) 1991-07-01
IE861033L (en) 1986-10-19
SE8601799D0 (sv) 1986-04-18
DK159780C (da) 1991-04-22
DK179786A (da) 1986-10-20
SE460196B (sv) 1989-09-18
HUT40433A (en) 1986-12-28
PT82424A (en) 1986-05-01
AU5638386A (en) 1986-10-23
SU1438612A3 (ru) 1988-11-15
PT82424B (pt) 1988-03-03
YU44286B (en) 1990-04-30
IT1204306B (it) 1989-03-01
YU62486A (en) 1988-06-30
SE8601799L (sv) 1986-10-20
BG60433B2 (bg) 1995-03-31
AR240699A1 (es) 1990-09-28
CN1023560C (zh) 1994-01-19
FI861641A (fi) 1986-10-20
CN86102479A (zh) 1986-10-22
GB2174701A (en) 1986-11-12
FR2580649B1 (fr) 1991-03-29
EG18059A (en) 1991-06-30
CH668262A5 (de) 1988-12-15
JPS61249986A (ja) 1986-11-07
FR2580649A1 (fr) 1986-10-24
DK159780B (da) 1990-12-03
FI861641A0 (fi) 1986-04-18
DE3613180A1 (de) 1986-10-23
AT390954B (de) 1990-07-25
ATA102986A (de) 1990-01-15
JPH072637B2 (ja) 1995-01-18
LU86397A1 (zh) 1986-09-02
CA1299574C (en) 1992-04-28
GB2174701B (en) 1989-02-15
US4806545A (en) 1989-02-21
FI83870C (fi) 1991-09-10
IN162810B (zh) 1988-07-09
IL78538A (en) 1989-10-31
GB8609533D0 (en) 1986-05-21
NZ215879A (en) 1989-04-26
CS286386A2 (en) 1990-09-12
ES8706152A1 (es) 1987-06-01
NO861539L (no) 1986-10-20
IT8620136A0 (it) 1986-04-18
DK179786D0 (da) 1986-04-18
IL78538A0 (en) 1986-08-31
DE3613180C2 (de) 1995-10-19
ES554143A0 (es) 1987-06-01
GR861027B (en) 1986-08-12
CS274276B2 (en) 1991-04-11
BE904588A (fr) 1986-10-14
IE59199B1 (en) 1994-01-26
HU194221B (en) 1988-01-28

Similar Documents

Publication Publication Date Title
FI120094B (fi) Menetelmä terapeuttisesti käyttökelpoisten 1, 4- dihydrokinoksaliini-2,3-dionijohdannaisten valmistamiseksi
KR100554601B1 (ko) 초단기 작용성 신경근 차단제인 치환된 이소퀴놀린
DK168093B1 (da) Isoquinoliniumderivater, fremgangsmaade til deres fremstilling, farmaceutisk praeparat indeholdende disse samt deres anvendelse
JPH11501925A (ja) 置換Ｎ−アリールメチルおよびヘテロシクリルメチル−１Ｈ−ピラゾロ〔３，４−ｂ〕キノリン−４−アミン並びにそれらを含有する組成物
KR20050070036A (ko) Ｌ형 칼슘 채널을 차단하는 동시에 3형포스포디에스테라제의 활성을 억제할 수 있는디히드로피리딘 화합물
EP0369145B1 (en) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine derivatives and medicines comprising the same
NL8600976A (nl) (-)-1 beta-ethyl-1 alfa-hydroxymethyl-1,2,3,4,6,7,12,12 b alfa-octahydroindool2,3-achinolizine, werkwijze voor de bereiding ervan en farmaceutische preparaten met een dergelijke verbinding erin.
PT99264A (pt) Processo para a preparacao de derivados de pirrolo {2,3-d}-pirimidina e de composicoes farmaceuticas que os contem
FI85142B (fi) Foerfarande foer framstaellning av ergolinestrar.
US5580877A (en) Pyrazolo-quinoline derivatives for treating cerebral ischemia
JPH02108688A (ja) キノリン化合物
JPS5982386A (ja) 新規な降圧剤
US6057334A (en) Benzo[g]quinoline derivatives
KR880001079B1 (ko) (-)-1β-에틸-1α-히드록시메틸-1,2,3,4,6,7,12,12bα-옥타히드로인돌로[2,3-a]퀴놀리진의 제조방법
US4086343A (en) Acylated hydrazinopyridazine antihypertensives
EP0342577B1 (en) Use of dihydropyridine derivatives for the prophylaxis or treatment of cerebral circulation disorders
SI8610624A8 (sl) Postopek za pripravo optično aktivnega trans (-)-1 beta-etil-1alfa-hidroksimetil-1,2,3,4,6,7,12,12b alfa-oktahidroindolo/2,3-a/kinolizina
KR810000519B1 (ko) 치환 6-페닐-1, 2, 4-트리아졸로 [4, 3-b] 피리다진의 제조방법
HU195214B (en) Process for producing 12b-substituted-1-(hydroxymethyl)-octahydro-indolo /2,3-a/ quinolizine derivatives and pharmaceutical preparations comprising these compounds
US3895031A (en) 2,3,5,6-Tetrahydro-5-(indol-3-yl)-1H-pyrrolo{8 2,1-b{9 {8 1,3{9 benzodiazepines and their preparation
CS220313B2 (cs) Způsob výroby nových derivátů naftyridinu
GB2288800A (en) Pyrazolo-quinoline derivatives as NMDA and AMPA antagonists
JPS60214781A (ja) ピペラジン及びホモピペラジンの置換された１−（４−アミノ−６，７−ジアルコキシ−キナゾリニル）−４−シクロクロヘキセニル誘導体
IE49470B1 (en) Substituted quinazolines for the treatment of hypertension and bradycardia and as cardiotonic agents

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed